Patent assignee · US · COMPANY

Insmed Incorporated

63Patents
56Active
63Granted
54Portfolio score

Filing activity: May 11, 2001 → May 13, 2024 · 4 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9255064B2 Prostacyclin compounds, compositions and methods of use thereof Chemistry; Metallurgy 43 Active
US8226975B2 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Emerging Cross-Sectional Technologies 41 Active
US9469600B2 Prostacyclin compounds, compositions and methods of use thereof Chemistry; Metallurgy 36 Active
US8673348B2 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Emerging Cross-Sectional Technologies 34 Active
US8673349B2 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Emerging Cross-Sectional Technologies 34 Active
US8642075B2 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Emerging Cross-Sectional Technologies 34 Active
US6541522B2 Methods of using compositions containing hypotriglyceridemically active stilbenoids Human Necessities 32 Expired
US8802137B2 Sustained release of antiinfectives Emerging Cross-Sectional Technologies 31 Active
US8632804B2 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Emerging Cross-Sectional Technologies 30 Active
US8679532B2 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Emerging Cross-Sectional Technologies 30 Active
US9549939B2 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Emerging Cross-Sectional Technologies 29 Active
US9119783B2 Method of treating pulmonary disorders with liposomal amikacin formulations Human Necessities 27 Active
US9333214B2 Method for treating pulmonary disorders with liposomal amikacin formulations Human Necessities 27 Active
US9114081B2 Methods of treating pulmonary disorders with liposomal amikacin formulations Human Necessities 27 Active
US9402845B2 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Emerging Cross-Sectional Technologies 26 Active
US9511082B2 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Emerging Cross-Sectional Technologies 22 Active
US9549925B2 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Emerging Cross-Sectional Technologies 22 Active
US6552085B2 Compositions containing hypoglycemically active stilbenoids Human Necessities 20 Expired
US9737555B2 Method of treating pulmonary disorders with liposomal amikacin formulations Human Necessities 17 Active
US9925205B2 Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods of use thereof Human Necessities 17 Active
US9895385B2 Methods for treating pulmonary non-tuberculous mycobacterial infections Human Necessities 17 Active
US9827317B2 Sustained release of antiinfectives Emerging Cross-Sectional Technologies 17 Active
US10124066B2 Stabilized vancomycin formulations Emerging Cross-Sectional Technologies 17 Active
US9724301B2 Methods of treating pulmonary disorders with liposomal amikacin formulations Human Necessities 17 Active
US10064882B2 Methods of treating pulmonary disorders with liposomal amikacin formulations Human Necessities 15 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.